After activation by GLP-1, the endogenous transcription factor CREB (cAMP response element-binding protein) binds to the CRE response element, inducing transcription of the luciferase reporter
However, several products do allow limited room temperature storage before first use according to their FDA labels: Wegovy (semaglutide): Up to 28 days at or below 86F (30C) before use Trulicity (dulaglutide): Up to 14 days at or below 86F (30C) before use Mounjaro and Zepbound (tirzepatide): Up to 21 days at or below 86F (30C) before use Bydureon BCise (exenatide extended-release): Up to 4 weeks at or below 77F (25C) before use When storing unopened GLP-1 medications, patients should keep them in their original carton to protect them from light exposure, which can also degrade the active ingredient
Weight Loss Patterns Weight loss on these medications follows predictable patterns that differ from traditional dieting
While not approved for weight loss, its known to help people lose weight and is commonly prescribed off-label for chronic weight management
These reports vary widely in severity and timing, with some patients noting symptoms shortly after starting the medication or following dose increases, while others report intermittent or persistent discomfort throughout treatment
Recent advances and therapeutic benefits of Glucagon-Like peptide-1 (GLP-1) agonists in the management of Type 2 diabetes and associated metabolic disorders